Cargando…

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma

BACKGROUND: Few studies have estimated the real-world economic burden such as all-cause and follicular lymphoma (FL)-related costs and health care resource utilization (HCRU) in patients with FL. OBJECTIVES: This study evaluated outcomes in patients who were newly initiated with FL indicated regimen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fowler, Nathan H., Chen, Guifang, Lim, Stephen, Manson, Stephanie, Ma, Qiufei, Li, Frank (Yunfeng)
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539759/ https://www.ncbi.nlm.nih.gov/pubmed/33043061 http://dx.doi.org/10.36469/jheor.2020.16784

Ejemplares similares

Mutational patterns along different evolution paths of follicular lymphoma
por: Michaeli, Miri, et al.
Publicado: (2022)

Cancer Immunotherapy and the Immune Response in Follicular Lymphoma
por: Stenner, Frank, et al.
Publicado: (2018)

Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
por: Huntington, Scott F., et al.
Publicado: (2022)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

A rare case of follicular lymphoma of the bladder
por: DeSanto, Matthew, et al.
Publicado: (2023)

Primary follicular lymphoma of an extraordinarily large prostate: A case report and review of the literature
por: Williams, Isabella S.C., et al.
Publicado: (2023)

Treatment selection for patients with relapsed or refractory follicular lymphoma
por: Skarbnik, Alan Z., et al.
Publicado: (2023)

Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma
por: Takada, Ryutaro, et al.
Publicado: (2021)

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
por: Kobayashi, Monica, et al.
Publicado: (2023)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)

Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
por: Marques-Piubelli, Mario L., et al.
Publicado: (2023)

Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)
por: Du, Jun, et al.
Publicado: (2023)

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
por: Rivero, Andrea, et al.
Publicado: (2023)

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Primary follicular lymphoma of the bladder mimicking inflammatory condition: Case report and review of the literature
por: Haghi, Nina, et al.
Publicado: (2019)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

Secondary Cutaneous Involvement in Follicular Diffuse Lymphoma Treated with Helical Tomotherapy
por: Dar, A. Rashid, et al.
Publicado: (2017)

Disparities in Receipt of Radiotherapy and Survival by Age, Sex, and Ethnicity among Patient with Stage I Follicular Lymphoma
por: Bista, Amir, et al.
Publicado: (2016)

Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China
por: Gao, Fenghua, et al.
Publicado: (2022)

Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China
por: Liu, Jiaxin, et al.
Publicado: (2023)

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
por: So, Heejune, et al.
Publicado: (2023)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population
por: Baker, Kellan, et al.
Publicado: (2022)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study
por: Lee, Shing Fung, et al.
Publicado: (2017)

Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma
por: Wang, Huan-You, et al.
Publicado: (2021)

Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances
por: Lage, Luís Alberto de Pádua Covas, et al.
Publicado: (2023)

Angioimmunoblastic T-cell lymphoma with extensive follicular dendritic cell and fibroblastic reticular cell network proliferation mimicking follicular dendritic cell sarcoma: A case report with pathologic, immunophenotypic, and molecular findings
por: Zhang, Fen, et al.
Publicado: (2022)

SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
por: Provencio Pulla, M., et al.
Publicado: (2015)

The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma
por: Hu, Jiaci, et al.
Publicado: (2023)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Follicular Dendritic Cell Sarcoma With Co-Expression of CD4 and CD30 Mimics Anaplastic Large Cell Lymphoma
por: Liu, Hui, et al.
Publicado: (2020)

Secondary Hemophagocytic Lymphohistiocytosis With Epstein–Barr Virus-Associated Transformed Follicular Lymphoma: A Case Report and Literature Review
por: Xu, Huan, et al.
Publicado: (2021)

An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
por: Lu, Yaxiao, et al.
Publicado: (2021)

Interpreting flow cytometry with caution: A case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia
por: Ren, Yuan, et al.
Publicado: (2023)

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013
por: McPherson, Timothy, et al.
Publicado: (2016)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study
por: Margolis, Jay M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vl40qeeha1n79l4bgish236m41